文献速递肿瘤 PET/CT

虚拟皮肤面积严重指数(vCASI):一种在正电子发射断层扫描图像上定量评估皮肤病的综合方法

Virtual cutaneous area severity index (vCASI): A comprehensive methodology for quantitative skin disease assessment on positron emission tomography images.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-06-23

研究提出虚拟皮肤面积严重指数(vCASI)方法,用于从FDG-PET/CT图像定量评估代谢活跃皮肤病的范围和严重程度。方法包括自动体区定位、PET图像标准化、皮肤壳PET图像和标准化最大强度投影渲染,以及新的vCASI评分系统。vCASI评分与参考标准的相关性在标准化后提高,最高达0.605;重复评估相关性在躯干、胸部、腹部和骨盆超过0.85。

要点

  • vCASI方法可对FDG-PET/CT上代谢活跃皮肤病进行定量评估。
  • vCASI评分与参考标准相关性最高达0.605。
  • 重复vCASI评分在躯干、胸部、腹部和骨盆相关性超过0.85。

核心结论

  • vCASI方法能够对FDG-PET/CT图像上代谢活跃的皮肤病(如皮肤淋巴瘤和银屑病)进行准确且可重复的定量评估。

研究设计与样本

  • 研究提出并验证了一种名为虚拟皮肤面积严重指数(vCASI)的综合方法,用于从FDG-PET/CT图像定量评估代谢活跃皮肤病的范围和严重程度。

主要发现

  • vCASI评分与参考标准真实评估的相关性在PET图像标准化后增加,在使用调整的最大百分位强度均值作为MIP渲染参考点后进一步提高,达到高达0.605。
  • 重复vCASI评分评估在躯干、胸部、腹部和骨盆的相关性超过0.85,表明高重复性。

关键数值与推荐

  • vCASI评分与参考标准的相关性最高达0.605。
  • 重复vCASI评分在躯干、胸部、腹部和骨盆的相关性超过0.85。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Quantification of skin diseases such as cutaneous lymphoma or psoriasis is important for pretreatment planning and response assessment. Currently, this quantification relies on clinical assessments, which are cumbersome, error-prone, and subject to inter-reader variability. FDG-PET/CT is a widely used molecular imaging technique for non-invasive detection and quantification of metabolically active disorders, providing biomarkers of disease extent, severity, and therapeutic response. However, skin disease quantification from PET/CT images remains challenging, error-prone, and labor-intensive. METHODS: We proposed a novel comprehensive methodology called virtual Cutaneous Area Severity Index (vCASI) to quantitatively assess the extent and severity of metabolically active skin disease from FDG-PET/CT images. Firstly, we used an automated body region localization method, followed by a standardization technique for PET images to reduce interscan measurement variability. Then, we generated skin shell PET images and developed a standardized Maximum Intensity Projection (MIP) rendering technique to enable reproducible 3D visualization of the skin with the disease. Finally, we introduced and validated a new quantitative scoring system (vCASI score) to measure the extent and severity of skin disease via these renderings. RESULTS: Correlations between vCASI scores and reference standard ground-truth assessments increased following the standardization of PET images, further improved with the use of adjusted mean of maximum percentile intensity values as the reference point for MIP rendering, and reached as high as 0.605. Additionally, correlations between repeated vCASI score assessments for the torso, thorax, abdomen, and pelvis exceeded 0.85, demonstrating high repeatability. CONCLUSIONS: The vCASI methodology allows for accurate and reproducible quantitative assessment of the extent and severity of metabolically active skin diseases, such as cutaneous lymphoma and psoriasis, from FDG-PET/CT images. It addresses the challenges related to body region localization, non-standardness of PET images, robust visualization, and standardized display of PET images to detect and quantify skin disease. Additionally, it overcomes the lack of a practical and validated scoring system for quantifying skin disease on PET images. We demonstrated that the vCASI scoring system has high repeatability and good accuracy, and is optimized by the proposed methodology.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Mortazi A, Udupa JK, Hosseini M, et al. Virtual cutaneous area severity index (vCASI): A comprehensive methodology for quantitative skin disease assessment on positron emission tomography images. Eur J Nucl Med Mol Imaging. 2025. PMID: 40545498. doi:10.1007/s00259-025-07423-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。